bepmed |

2698867
l 2009
CA

4961. BIOACTIVE NANOCOMPOSITE MATERIAL

Abstract

The present invention relates to a porous inorganic/organic hybrid nanoscale composite comprising an enzymatically biodegradable organic polymer and a sol-gel derived silica network, its production...

13:51 / methods / Scaffolds

2704738
l 2009
CA

4962. METHOD FOR PREPARING POROUS SCAFFOLD FOR TISSUE ENGINEERING

Abstract

The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide...

13:51 / methods / Scaffolds

2702335
l 2009
CA

4963. MICROSPHERE-BASED MATERIALS WITH PREDEFINED 3D SPATIAL AND TEMPORAL CONTROL OF BIOMATERIALS, POROSITY AND/OR BIOACTIVE SIGNALS

Abstract

A tissue engineering scaffold for growing cells can include a plurality of biocompatible microspheres linked together to form a three-dimensional matrix. The matrix can include...

13:51 / rest

2008315318
l 2009
AU

4964. Biodegradable polymer scaffold and process for preparation thereof

Abstract

Year: 2009 Country: AU Doc No: 2008315318 For more information visit espacenet.com Read more...

13:51 / methods / Scaffolds

2708039
l 2009
CA

4965. USE OF COUPLING AGENTS TO IMPROVE THE INTERFACE IN ABSORBABLE POLYMER COMPOSITES

Abstract

A composite having a poly(ethylene-co-acrylic acid) coupling agent, a filler, and a biocompatible, biodegradable polymer matrix is disclosed. The composites described herein are useful for...

13:51 / methods / thereof

2705320
l 2009
CA

4966. BIODEGRADABLE COLLOIDAL GELS AS MOLDABLE TISSUE ENGINEERING SCAFFOLDS

Abstract

A colloid gel can include a plurality of positive charged particles mixed and associated with a plurality of negative charged particles so as to form...

13:51 / methods / Scaffolds

2702376
l 2009
CA

4967. MARKERS OF MATRIX GENE EXPRESSION AND CELLULAR DIFFERENTIATION IN CHONDROCYTES

Abstract

The invention relates generally to the field of tissue engineering. More particularly, the present invention relates to methods for identifying a population of cells suitable...

13:51 / cells / methods

2729923
l 2009
CA

4968. DEHYDRATED CHITOSAN NANOPARTICLES

Abstract

The present invention relates to dehydrated nanoparticles comprising chitosan and a nucleic acid. Preferably, the nucleic acid is a siRNA. Dehydrated nanoparticles of the invention...

13:51 / methods / Scaffolds

2715642
l 2009
CA

4969. TISSUE ENGINEERING SCAFFOLDS

Abstract

The present invention relates to tissue engineering scaffolds (TE scaffolds) that mimic the biomechanical behavior of native blood vessels, tissue engineered blood vessels (TEBVs) derived...

13:51 / methods / Scaffolds

2009257400
l 2009
AU

4970. Solutions for tissue engineering and methods of use

Abstract

Year: 2009 Country: AU Doc No: 2009257400 For more information visit espacenet.com Read more...

13:51 / cells / methods

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract